Orthopedic surgeons’ political awakening 

Advertisement

Hip and knee replacement has become a model of surgical efficiency. Patients who once spent days in the hospital are increasingly recovering at home, supported by preoperative optimization programs and care teams that manage much of their recovery outside the hospital.

But Adam Rana, MD, sees a contradiction at the center of that progress with respect to Medicare.

“We’re taking better care of patients in a more efficient manner,” Dr. Rana told Becker’s. “And how does CMS acknowledge that? They acknowledge that with continued cuts to the physician fee schedule, which is not a sustainable path forward.”

Now, hip and knee surgeons are taking their frustration beyond the operating room and into federal politics.

Dr. Rana, director of the Joint Replacement Center at Portland-based Maine Medical Center and chair of the American Association of Hip and Knee Surgeons’ new political action committee, ArthroPAC, said the specialty has reached a turning point. After years of pressing policymakers to recognize the changing economics of joint replacement, surgeons are now investing in a more direct political voice.

The work that followed patients home

When Dr. Rana began practicing about 15 years ago, patients typically remained hospitalized for three days after hip or knee replacement. Roughly 40% went to rehabilitation facilities. Today, he said, about half of his patients go home the same day and the other half leave the following day. 

That shift has changed far more than the length of a hospital stay. Surgeons and their teams now manage increasingly complex preoperative preparation and postoperative recovery, including patient education, medical optimization and ongoing communication after discharge.

Much of that work has migrated from hospitals to physician offices. At Maine Medical Center, Dr. Rana said an institutional analysis found that patients averaged nine separate contacts with their care teams during the 90-day postoperative period. He contrasted that figure with the two postoperative visits he said are reflected in Medicare’s payment assumptions.

Electronic messages exchanged with patients also increased 500% over five years, according to the analysis.

“The work gets pushed onto the physician’s office as opposed to the hospital,” he said.

For Dr. Rana, those figures expose a fundamental weakness in how surgical work is valued. The operation itself may be more efficient, but the resources needed to prepare patients and support their recovery have not disappeared but shifted. And as physician practices assume those responsibilities, continued reimbursement pressure makes it harder to invest in the staff and infrastructure needed to sustain them.

Dr. Rana is particularly concerned about the consequences for independent practices, which may have fewer resources to absorb additional work as payments decline.

A $370,000 response to Medicare cuts

That frustration became unmistakable at the AAHKS’ annual meeting in November. Surgeons arrived just after CMS finalized its 2027 Medicare Physician Fee Schedule, which included substantial reductions for hip and knee replacement procedures.

Although CMS moderated some of its initially proposed cuts, the final policy remained a significant concern for the specialty.

For Dr. Rana, the announcement added to years of mounting frustration over reimbursement and the growing demands placed on joint replacement practices.

The AAHKS had planned to launch ArthroPAC with an ambitious fundraising goal of $200,000. Within three days, more than 375 donors had contributed over $370,000.

The response, Dr. Rana said, reflected a membership ready to turn frustration into action.

ArthroPAC will support federal candidates from both parties whose priorities align with those of hip and knee surgeons. The committee is designed to complement the AAHKS’ existing legislative and regulatory advocacy by adding a more direct role in electoral politics.

The distinction is deliberate. The AAHKS has spent years engaging Congress, CMS and other federal officials on reimbursement, quality reporting and payment models. ArthroPAC gives the specialty another way to build relationships with policymakers who influence those decisions.

Dr. Rana emphasized that the committee is not intended to compete with other medical or orthopedic political action committees. Its purpose is to bring additional attention to the challenges facing arthroplasty surgeons.

Those challenges extend beyond reimbursement. Hip and knee surgeons have also faced mandatory bundled payment programs, patient-reported outcome requirements and other regulatory changes that affect how they deliver care.

But reimbursement remains the issue driving much of the specialty’s political urgency.

Why surgeons need a different message

Dr. Rana said he recognizes that a campaign focused exclusively on physician compensation is unlikely to win widespread public sympathy, adding that the argument must be about what continued payment pressure means for patients.

“We love what we do,” he said. “These continued cuts are going to really impact access to care.”

He said he worries that declining reimbursement could make independent orthopedic practices increasingly difficult to sustain, contributing to consolidation and potentially limiting patients’ choices.

The concern is particularly significant as practices invest in the infrastructure required to manage more care outside the hospital.

Dr. Rana believes policymakers need to understand that improving surgical efficiency does not necessarily mean reducing the total work involved in treating a patient. And he wants the specialty to make that case in terms that resonate beyond the operating room.

The question, as he sees it, is not simply how much surgeons are paid. It is whether the payment system can continue supporting the care patients need.

The next step isn’t just about money

ArthroPAC’s early fundraising success gives hip and knee surgeons a new political tool. But Dr. Rana believes their greatest influence may ultimately come from the patients they treat.

The AAHKS estimates that approximately 1.5 million hip and knee replacements are performed annually in the U.S., with its members performing more than half.

Those patients are also voters, many of them Medicare beneficiaries with a direct stake in federal healthcare policy.

“The holy grail of advocacy is patient advocacy,” Dr. Rana said. The AAHKS is exploring ways to engage patients more directly in its advocacy efforts, creating another channel for communicating how payment policy could affect access to orthopedic care.

For Dr. Rana, the strategy has several parts: strengthening relationships with lawmakers, supporting candidates who understand the specialty’s concerns and bringing patients into conversations that have largely been dominated by physicians and policymakers.

None of it will produce immediate change. “There’s not a light switch where all of a sudden there’s action,” he said.

The challenge now is sustaining the momentum behind ArthroPAC long enough to influence policy decisions.

Dr. Rana believes the specialty has already demonstrated its ability to transform patient care. Shorter hospital stays, more sophisticated preparation and expanded recovery support have changed what joint replacement looks like.

But the payment system governing that work remains a source of growing tension. For hip and knee surgeons, the next test may be whether they can translate the progress made inside their practices into greater influence over the policies shaping their future.

Advertisement

Next Up in Orthopedic

Advertisement